Exploring gut microbiota and metabolite alterations in patients with thyroid-associated ophthalmopathy using high-throughput sequencing and untargeted metabolomics
Open Access
- 29 July 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1413890
Abstract
Introduction: Thyroid-associated ophthalmopathy (TAO) is an autoimmune-driven orbital inflammatory disease. Despite research efforts, its exact pathogenesis remains unclear. This study aimed to characterize the intestinal flora and metabolic changes in patients with TAO to identify the flora and metabolites associated with disease development.Methods: Thirty patients with TAO and 29 healthy controls were included in the study. The intestinal flora and metabolites were analyzed using high-throughput sequencing of the 16S rRNA gene and non-targeted metabolomics technology, respectively. Fresh fecal samples were collected from both populations for analysis.Results: Reduced gut richness and diversity were observed in patients with TAO. Compared to healthy controls, significant differences in relative abundance were observed in patients with TAO at the order level Clostridiales, family level Staphylococcaceae, genus level Staphylococcus, Fournierella, Eubacterium siraeum, CAG-56, Ruminococcus gnavus, Intestinibacter, Actinomyces, and Erysipelotrichaceae UCG-003 (logFC>1 and PVeillonella and Megamonas were closely associated with clinical symptoms in patients with TAO. Among the 184 significantly different metabolites, 63 were upregulated, and 121 were downregulated in patients with TAO compared to healthy controls. The biosynthesis of unsaturated fatty acids was the significantly enriched metabolic pathway. Correlation analysis revealed Actinomyces was positively correlated with NAGlySer 15:0/16:0, FAHFA 3:0/20:0, and Lignoceric Acid, while Ruminococcus gnavu was positively correlated with Cer 18:0;2O/16:0; (3OH) and ST 24:1;O4/18:2.Conclusion: Specific intestinal flora and metabolites are closely associated with TAO development. Further investigation into the functional associations between these flora and metabolites will enhance our understanding of TAO pathogenesis.Keywords
This publication has 48 references indexed in Scilit:
- Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidenceHormones, 2023
- The risk factors for Graves’ ophthalmopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2021
- Gut microbiome and thyroid autoimmunityBest Practice & Research Clinical Endocrinology & Metabolism, 2021
- Comparative assessment of gut microbial composition and function in patients with Graves’ disease and Graves’ orbitopathyJournal of Endocrinological Investigation, 2020
- Graves’ disease: Epidemiology, genetic and environmental risk factors and virusesBest Practice & Research Clinical Endocrinology & Metabolism, 2020
- Regulation of insulin resistance by targeting the insulin‐like growth factor 1 receptor with microRNA‐122‐5p in hepatic cellsCell Biology International, 2019
- Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: a cross-sectional studyJournal of Endocrinological Investigation, 2019
- Lipidomic differentiation of Graves’ ophthalmopathy in plasma and urine from Graves’ disease patientsAnalytical and Bioanalytical Chemistry, 2018
- The frequency of Th17 cells in the small intestine exhibits a day–night variation dependent on circadian clock activityBiochemical and Biophysical Research Communications, 2017
- Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel DiseaseArthritis & Rheumatology, 2014